Usefulness of Microvolt T-Wave Alternans on Predicting Outcome in Patients With Ischemic Cardiomyopathy With and Without Defibrillators

American Journal of Cardiology

Volumn 100, Issue 4, 2007, Pages 598-604

  Chow, Theodore ^a   Saghir, Sayed ^a   Bartone, Cheryl ^a   Goebel, Megan ^a   Schneider, Julia ^a   Booth, Terri ^a   Chan, Paul S ^b  

^a The Carl & Edyth Lindner Center for Research & Education   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEFIBRILLATOR; DEMOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QRS COMPLEX; T WAVE;

AGED; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OHIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34547680322     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.069     Document Type: Article

References (12)

1. Gehi A.K., Stein R.H., Metz L.D., and Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
2. Chow T., Kereiakes D.J., Bartone C., Booth T., Schloss E.J., Waller T., Chung E., Menon S., Nallamothu B.K., and Chan P.S. Prognostic utility of microvolt T-wave alternans in risk stratifying patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
3. Rashba E.J., Osman A.F., MacMurdy K., Kirk M.M., Sarang S., Peters R.W., Shorofsky S.R., and Gold M.R. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 13 (2002) 770-775
4. Chan P.S., Stein K., Chow T., Fendrick M., Bigger J.T., and Vijan S. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J Am Coll Cardiol 48 (2006) 112-121
5. Chow T., Kereiakes D.J., Bartone C., Booth T., Schloss E.J., Waller T., Chung E., Menon S., Nallamothu B.K., and Chan P.S. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49 (2007) 50-58
6. Bloomfield D.M., Hohnloser S.H., and Cohen R.J. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 13 (2002) 502-512
7. Kaufman E.S., Bloomfield D.M., Steinman R.C., Namerow P.B., Costantini O., Cohen R.J., and Bigger Jr. J.T. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48 (2006) 1399-1404
8. Hinkle Jr. L.E., and Thaler H.T. Clinical classification of cardiac deaths. Circulation 65 (1982) 457-464
9. Bloomfield D.M., Steinman R.C., Namerow P.B., Parides M., Davidenko J., Kaufman E.S., Shinn T., Curtis A., Fontaine J., Holmes D., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
10. Buxton A.E., Sweeney M.O., Wathen M.S., Josephson M.E., Otterness M.F., Hogan-Miller E., Stark A.J., and Degroot P.J. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol 46 (2005) 310-316
11. Moss A.J., Zareba W., Hall W.J., Klein h., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
12. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237